Parry A - Search Results

1

White matter and lesion T1 relaxation times increase in parallel and correlate with disability in multiple sclerosis.

Parry A, Clare S, Jenkinson M, Smith S, Palace J, Matthews PM. Parry A, et al. J Neurol. 2002 Sep;249(9):1279-86. doi: 10.1007/s00415-002-0837-7. J Neurol. 2002. PMID: 12242554

2

Beta-Interferon treatment does not always slow the progression of axonal injury in multiple sclerosis.

Parry A, Corkill R, Blamire AM, Palace J, Narayanan S, Arnold D, Styles P, Matthews PM. Parry A, et al. J Neurol. 2003 Feb;250(2):171-8. doi: 10.1007/s00415-003-0965-8. J Neurol. 2003. PMID: 12574947 Clinical Trial.

3

MRI brain T1 relaxation time changes in MS patients increase over time in both the white matter and the cortex.

Parry A, Clare S, Jenkinson M, Smith S, Palace J, Matthews PM. Parry A, et al. J Neuroimaging. 2003 Jul;13(3):234-9. J Neuroimaging. 2003. PMID: 12889170

4

Roles for imaging in understanding the pathophysiology, clinical evaluation, and management of patients with mitochondrial disease.

Parry A, Matthews PM. Parry A, et al. J Neuroimaging. 2003 Oct;13(4):293-302. J Neuroimaging. 2003. PMID: 14569820 Review.

5

MRI criteria for dissemination in space in patients with clinically isolated syndromes: a multicentre follow-up study.

Korteweg T, Tintoré M, Uitdehaag B, Rovira A, Frederiksen J, Miller D, Fernando K, Filippi M, Agosta F, Rocca M, Fazekas F, Enzinger C, Matthews P, Parry A, Polman C, Montalban X, Barkhof F. Korteweg T, et al. Among authors: parry a. Lancet Neurol. 2006 Mar;5(3):221-7. doi: 10.1016/S1474-4422(06)70353-2. Lancet Neurol. 2006. PMID: 16488377

6

Long term survival in a patient with variant Creutzfeldt-Jakob disease treated with intraventricular pentosan polysulphate.

Parry A, Baker I, Stacey R, Wimalaratna S. Parry A, et al. J Neurol Neurosurg Psychiatry. 2007 Jul;78(7):733-4. doi: 10.1136/jnnp.2006.104505. Epub 2007 Feb 21. J Neurol Neurosurg Psychiatry. 2007. PMID: 17314188 Free PMC article.

7

Novel Variant of Miller Fisher Syndrome Occurring With Tumor Necrosis Factor α Antagonist Therapy.

Ratnarajan G, Thompson A, Dodridge C, Parry A, Elston J. Ratnarajan G, et al. Among authors: parry a. JAMA Neurol. 2015 Nov;72(11):1377-8. doi: 10.1001/jamaneurol.2015.2251. JAMA Neurol. 2015. PMID: 26551961 No abstract available.

8

Thunderclap headache.

Mistry N, Mathew L, Parry A. Mistry N, et al. Among authors: parry a. Pract Neurol. 2009 Oct;9(5):294-7. doi: 10.1136/jnnp.2009.188037. Pract Neurol. 2009. PMID: 19762891 No abstract available.

9

Longitudinal evaluation of quality of life in 288 patients with neurofibromatosis 2.

Ferner RE, Shaw A, Evans DG, McAleer D, Halliday D, Parry A, Raymond FL, Durie-Gair J, Hanemann CO, Hornigold R, Axon P, Golding JF. Ferner RE, et al. Among authors: parry a. J Neurol. 2014 May;261(5):963-9. doi: 10.1007/s00415-014-7303-1. Epub 2014 Mar 12. J Neurol. 2014. PMID: 24619350 Free PMC article.

10

Current whole-body MRI applications in the neurofibromatoses: NF1, NF2, and schwannomatosis.

Ahlawat S, Fayad LM, Khan MS, Bredella MA, Harris GJ, Evans DG, Farschtschi S, Jacobs MA, Chhabra A, Salamon JM, Wenzel R, Mautner VF, Dombi E, Cai W, Plotkin SR, Blakeley JO; Whole Body MRI Committee for the REiNS International Collaboration; REiNS International Collaboration Members 2016. Ahlawat S, et al. Neurology. 2016 Aug 16;87(7 Suppl 1):S31-9. doi: 10.1212/WNL.0000000000002929. Neurology. 2016. PMID: 27527647 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

538 results

Search Page